• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于免疫调节剂时空控制递送的水凝胶系统:构建肿瘤免疫微环境以增强癌症免疫治疗

Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy.

作者信息

Liu Yanting, Liu Fang, Zeng Yan, Lin Liangbin, Yu Hui, Zhang Sunfu, Yang Wenyong

机构信息

Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China.

Department of Neurosurgery, Department of Urology, Medical Research Center, The Second Chengdu Hospital Affiliated to Chongqing Medical University, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.

出版信息

Front Cell Dev Biol. 2024 Dec 13;12:1514595. doi: 10.3389/fcell.2024.1514595. eCollection 2024.

DOI:10.3389/fcell.2024.1514595
PMID:39735340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681625/
Abstract

Tumor immunotherapy, modulating innate and adaptive immunity, has become an important therapeutic strategy. However, the tumor immune microenvironment's (TIME) complexity and heterogeneity challenge tumor immunotherapy. Hydrogel is a hydrophilic three-dimensional (3D) mesh structure with good biocompatibility and drug release control, which is widely used in drug delivery, agriculture, industry, etc. Hydrogels loaded with immune cells, cytokines, immune checkpoint inhibitors, and anti-tumor drugs can achieve targeted delivery and ultimately activate the immune response in the TIME. In this review, we will summarize the components of the TIME and their immune effects, the emerging immunomodulatory agents, the characteristics and functions of hydrogels, and how hydrogels regulate innate and adaptive immune cells in the TIME.

摘要

肿瘤免疫疗法可调节固有免疫和适应性免疫,已成为一种重要的治疗策略。然而,肿瘤免疫微环境(TIME)的复杂性和异质性对肿瘤免疫疗法构成了挑战。水凝胶是一种具有良好生物相容性和药物释放控制能力的亲水性三维(3D)网状结构,广泛应用于药物递送、农业、工业等领域。负载免疫细胞、细胞因子、免疫检查点抑制剂和抗肿瘤药物的水凝胶能够实现靶向递送,并最终激活TIME中的免疫反应。在这篇综述中,我们将总结TIME的组成部分及其免疫效应、新兴的免疫调节因子、水凝胶的特性和功能,以及水凝胶如何调节TIME中的固有免疫细胞和适应性免疫细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/69f27f0e7190/fcell-12-1514595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/6c87fed211ba/fcell-12-1514595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/311cc7a1d215/fcell-12-1514595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/69f27f0e7190/fcell-12-1514595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/6c87fed211ba/fcell-12-1514595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/311cc7a1d215/fcell-12-1514595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8105/11681625/69f27f0e7190/fcell-12-1514595-g003.jpg

相似文献

1
Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy.用于免疫调节剂时空控制递送的水凝胶系统:构建肿瘤免疫微环境以增强癌症免疫治疗
Front Cell Dev Biol. 2024 Dec 13;12:1514595. doi: 10.3389/fcell.2024.1514595. eCollection 2024.
2
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.基于可注射多肽水凝胶的疫苗和免疫检查点抑制剂共递送提高了肿瘤免疫治疗效果。
Theranostics. 2019 Apr 12;9(8):2299-2314. doi: 10.7150/thno.30577. eCollection 2019.
3
A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response.一种自发多功能水凝胶疫苗增强了先天免疫反应,从而引发强大的抗肿瘤适应性免疫反应。
Theranostics. 2021 May 8;11(14):6936-6949. doi: 10.7150/thno.58173. eCollection 2021.
4
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer.癌症免疫循环的现状:使用精准水凝胶治疗乳腺癌的新策略与挑战
Front Immunol. 2025 Mar 7;16:1535464. doi: 10.3389/fimmu.2025.1535464. eCollection 2025.
5
Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations.超分子纤维水凝胶作为一种通用免疫调节剂载体用于免疫治疗联合疗法。
ACS Nano. 2023 Jun 13;17(11):10651-10664. doi: 10.1021/acsnano.3c01748. Epub 2023 May 22.
6
Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy.水凝胶/纳米颗粒介导的抗血管生成与免疫治疗协同联合。
Acta Biomater. 2022 Nov;153:124-138. doi: 10.1016/j.actbio.2022.09.060. Epub 2022 Sep 28.
7
Tumor-Targeted Nanomedicine for Immunotherapy.肿瘤靶向纳米医学免疫治疗。
Acc Chem Res. 2020 Dec 15;53(12):2765-2776. doi: 10.1021/acs.accounts.0c00518. Epub 2020 Nov 8.
8
Short Review on Advances in Hydrogel-Based Drug Delivery Strategies for Cancer Immunotherapy.水凝胶基药物输送策略在癌症免疫治疗中的进展综述
Tissue Eng Regen Med. 2022 Apr;19(2):263-280. doi: 10.1007/s13770-021-00369-6. Epub 2021 Oct 1.
9
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways.揭示赖氨酸特异性去甲基化酶1(LSD1)在肿瘤免疫中的双重作用:固有免疫和适应性免疫途径
Theranostics. 2024 Oct 21;14(18):7054-7071. doi: 10.7150/thno.102037. eCollection 2024.
10
Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer.治疗性超分子管状水凝胶联合检查点抑制剂引发免疫反应以对抗癌症。
Biomaterials. 2021 Dec;279:121182. doi: 10.1016/j.biomaterials.2021.121182. Epub 2021 Oct 11.

引用本文的文献

1
Chitosan-Glycerol Injectable Hydrogel for Intratumoral Delivery of Macromolecules.用于瘤内递送大分子的壳聚糖-甘油可注射水凝胶
Gels. 2025 Aug 2;11(8):607. doi: 10.3390/gels11080607.
2
Hydrogels as advanced drug delivery platforms for cancer immunotherapy: promising innovations and future outlook.水凝胶作为癌症免疫治疗的先进药物递送平台:有前景的创新与未来展望。
J Nanobiotechnology. 2025 Jul 28;23(1):545. doi: 10.1186/s12951-025-03613-6.
3
Dual-Drug Delivery Systems Using Hydrogel-Nanoparticle Composites: Recent Advances and Key Applications.

本文引用的文献

1
Stimulus-Responsive Hydrogels for Targeted Cancer Therapy.用于靶向癌症治疗的刺激响应性水凝胶
Gels. 2024 Jul 1;10(7):440. doi: 10.3390/gels10070440.
2
Dynamic Hybrid Module-Driven NK Cell Stimulation and Release for Tumor Immunotherapy.动态混合模块驱动的自然杀伤细胞刺激和释放用于肿瘤免疫治疗。
Nano Lett. 2024 May 8;24(18):5481-5489. doi: 10.1021/acs.nanolett.4c00425. Epub 2024 Apr 19.
3
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.STING 激动剂激活宫颈癌免疫微环境并克服抗 PD-1 治疗耐药性。
使用水凝胶-纳米颗粒复合材料的双药递送系统:最新进展与关键应用
Gels. 2025 Jul 3;11(7):520. doi: 10.3390/gels11070520.
4
CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence.嵌合抗原受体T细胞疗法在脑恶性肿瘤中的应用:细胞转运与存活面临的障碍
Front Immunol. 2025 Jun 19;16:1596499. doi: 10.3389/fimmu.2025.1596499. eCollection 2025.
5
Hydrogels in Veterinary Vaccine Development: Types, Mechanisms, and Applications.兽医疫苗开发中的水凝胶:类型、作用机制及应用
Gels. 2025 Jun 18;11(6):468. doi: 10.3390/gels11060468.
6
Immune checkpoint blocking in cancer therapy using thermosensitive hydrogels: a review.基于热敏水凝胶的癌症免疫检查点阻断疗法综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 2. doi: 10.1007/s00210-025-04171-2.
7
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.肿瘤浸润细胞免疫功能悖论及其免疫治疗靶点的当前进展:一篇综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 10. doi: 10.1007/s00210-025-03985-4.
Front Immunol. 2024 Mar 14;15:1342647. doi: 10.3389/fimmu.2024.1342647. eCollection 2024.
4
Advancing burn wound treatment: exploring hydrogel as a transdermal drug delivery system.推进烧伤创面治疗:探索水凝胶作为经皮给药系统。
Drug Deliv. 2024 Dec;31(1):2300945. doi: 10.1080/10717544.2023.2300945. Epub 2024 Feb 16.
5
Participation of B cell in immunotherapy of cancer.B细胞在癌症免疫治疗中的参与。
Pathol Res Pract. 2024 Mar;255:155169. doi: 10.1016/j.prp.2024.155169. Epub 2024 Jan 26.
6
Research progress on hydrogel-based drug therapy in melanoma immunotherapy.基于水凝胶的药物治疗在黑色素瘤免疫治疗中的研究进展。
BMB Rep. 2024 Feb;57(2):71-78. doi: 10.5483/BMBRep.2023-0160.
7
Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.曲马多通过促进肿瘤微环境中M1巨噬细胞极化来抑制原位肝肿瘤的生长。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):4205-4218. doi: 10.1007/s00210-023-02871-1. Epub 2023 Dec 2.
8
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.蛋白酪氨酸磷酸酶N2/蛋白酪氨酸磷酸酶N1抑制剂ABBV-CLS-484可释放强大的抗肿瘤免疫力。
Nature. 2023 Oct;622(7984):850-862. doi: 10.1038/s41586-023-06575-7. Epub 2023 Oct 4.
9
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target.增强黑色素瘤的免疫治疗反应:髓系来源的抑制细胞作为治疗靶点。
J Clin Invest. 2023 Jul 3;133(13):e170762. doi: 10.1172/JCI170762.
10
Hydrogel-Based Biomaterial as a Scaffold for Gingival Regeneration: A Systematic Review of In Vitro Studies.基于水凝胶的生物材料作为牙龈再生支架:体外研究的系统评价
Polymers (Basel). 2023 Jun 6;15(12):2591. doi: 10.3390/polym15122591.